Angioplasty on Ganguly's other coronary blockages to be done later

BCCI President Sourav Ganguly is stable and the angioplasty on the two other coronary blockages to be done at an 'immediate later stage'

Sourav Ganguly
BCCI president Sourav Ganguly | File
ANI Cricket
2 min read Last Updated : Jan 04 2021 | 2:58 PM IST

Board of Control for Cricket in India (BCCI) president Sourav Ganguly is stable and the angioplasty on the two other coronary blockages will be done at an 'immediate later stage', the nine-member medical board of the Woodlands Hospital said on Monday.

"The medical records and clinical condition of Sourav Ganguly were reviewed by the board members. The unanimous decision was that an appropriate timely excellent treatment of primary PTCA with revascularisation of RCA was rendered during the acute heart attack stage," the hospital said in the latest medical bulletin.

"The discussion was also on the two other coronary blockages viz LAD and OM2 need to be treated by angioplasty in this admission vis a vis doing it at an immediate later stage," the hospital added.

"The consensus of the board was that deferring the angioplasty for now is deemed to be a safer option since Ganguly is stable, without any chest pain and is on optimal medical management."

The hospital said that the doctors are keeping "constant vigil" on Ganguly's health situation and appropriate measures will be taken from time to time.

"Treating doctors will be keeping constant vigil on his health situation and taking appropriate measures daily at home once discharged," the hospital said.

The 48-year-old former skipper was hospitalised at 1 pm on Saturday with "chest discomfort, heaviness of head, vomiting and a spell of dizziness" while performing physical exercise in the home gymnasium at around 11 am. Following this, doctors had conducted angioplasty on him.

He was tested for the SARS-CoV-2 virus, whose result turned out to be negative.

The family members were present during the board meeting and were explained about the disease process and further therapeutic plan.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Sourav GangulyangioplastyHeart diseases

First Published: Jan 04 2021 | 2:46 PM IST

Next Story